{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:43:29Z","timestamp":1791517409695,"version":"4.3.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Medical expulsive therapy (MET) is recommended for ureteral stones when there is no indication for interventional treatment. Spontaneous passage (SP) may not always be perceived in patients undergoing MET. We aimed to demonstrate the effects of inflammatory factors on spontaneous ureteral stone passage in patients undergoing MET.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Our study was conducted between August and November, 2016, in healthy volunteers and patients with a single distal ureteral stone between 5 and 10\u2009mm in diameter and no indications for interventional therapy. Blood and urine samples from all patients and healthy volunteers were tested. The patients were followed up every 2 weeks for 1 month unless emergency situations appeared. Patients with stone-free status at follow-up were concluded to have achieved complete stone passage [SP(+)], and failure [SP(\u2212)] was concluded if the patient had not passed the stone by the end of the study. Blood samples of the patients and the control group were analyzed, recording WBC (white blood cell), CRP (c-reactive protein), SED (sedimentation), MPV (mean platelet volume), NLR (neutrophil-to-lymphocyte ratio), and serum procalcitonin levels. Abnormalities in urine samples were recorded. All patients received diclofenac sodium 75\u2009mg\/day, tamsulosin 0.4\u2009mg\/day, and at least 3\u2009l\/day fluid intake. Patients were followed for a month with kidney, ureter, bladder (KUB) plain films, ultrasonography (USG), and unenhanced abdominal CT scans while undergoing MET. Comparative statistical analyses were performed between the SP(+) and SP(\u2212) groups.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The procalcitonin levels of the SP(\u2212) group were significantly higher (207\u2009\u00b1\u2009145.1\u2009pg\/ml) than in the SP(+) group (132.7\u2009\u00b1\u200928.1\u2009pg\/ml) (<jats:italic>p<\/jats:italic>\u2009=\u20090.000). The leucocyturia rate of the SP(\u2212) group was significantly higher than in the SP(+) group (<jats:italic>p<\/jats:italic>\u2009=\u20090.004). Based on the ROC curve analysis, 160\u2009pg\/ml (86.7% sensitivity, 70.8% specificity, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; AUC: 0.788 95% CI (0.658\u20130.917) was identified as the optimal cut-off value for procalcitonin. In logistic regression analysis, a significant efficacy of procalcitonin and leucocyturia was observed in the univariate analysis on spontaneous passage. In the multivariate analysis, significant independent activity was observed with procalcitonin. (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Our findings suggest that high procalcitonin levels and the presence of leucocyturia have a strong negative effect on SP of ureteral stones between 5 and 10\u2009mm in diameter. This relationship can be explained by stone impaction, possibly caused by increased mucosal inflammation.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12894-020-00608-3","type":"journal-article","created":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T15:02:45Z","timestamp":1587308565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Can serum procalcitonin levels be useful in predicting spontaneous ureteral stone passage?"],"prefix":"10.1186","volume":"20","author":[{"given":"Nusret Can","family":"Cilesiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Kalkanli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Eroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem Tu\u011frul","family":"Gezmis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkan","family":"Simsek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,19]]},"reference":[{"issue":"3","key":"608_CR1","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.eururo.2015.07.040","volume":"69","author":"C T\u00fcrk","year":"2016","unstructured":"T\u00fcrk C, Pet\u0159\u00edk A, Sarica K, Seitz C, Skolarikos A, Straub M, et al. EAU guidelines on diagnosis and conservative Management of Urolithiasis. Eur Urol. 2016;69(3):468\u201374.","journal-title":"Eur Urol"},{"key":"608_CR2","doi-asserted-by":"crossref","unstructured":"Pak CY. Kidney stones. Lancet. 1998;351(9118):1797\u20131801. Review.","DOI":"10.1016\/S0140-6736(98)01295-1"},{"issue":"11\u201312","key":"608_CR3","doi-asserted-by":"publisher","first-page":"E837","DOI":"10.5489\/cuaj.3483","volume":"9","author":"M Ordon","year":"2015","unstructured":"Ordon M, Andonian S, Blew B, Schuler T, Chew B. Pace KT CUA, guideline: management of ureteral calculi. Can Urol Assoc J. 2015;9(11\u201312):E837\u201351.","journal-title":"Can Urol Assoc J"},{"key":"608_CR4","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.annemergmed.2007.05.015","volume":"50","author":"A Singh","year":"2017","unstructured":"Singh A, Alter HJ, Littlepage A. A systematic review of medical therapy to facilitate passage of ureteral calculi. Ann Emerg Med. 2017;50:552\u201363.","journal-title":"Ann Emerg Med"},{"issue":"4 Pt 1","key":"608_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.juro.2015.11.026","volume":"195","author":"C Loftus","year":"2016","unstructured":"Loftus C, Nyame Y, Hinck B, Greene D, Chaparala H, Alazem K, et al. Medical expulsive therapy is underused for the management of renal colic in the emergency setting. J Urol. 2016;195(4 Pt 1):987\u201391.","journal-title":"J Urol"},{"key":"608_CR6","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.juro.2009.10.019","volume":"183","author":"C Brede","year":"2010","unstructured":"Brede C, Hollingsworth JM, Faerber GJ, Taylor JS, Wolf JS Jr. Medical expulsive therapy for ureteral calculi in the real world: targeted education increases use and improves patient outcome. J Urol. 2010;183:585\u20139.","journal-title":"J Urol"},{"key":"608_CR7","doi-asserted-by":"crossref","unstructured":"Furyk JS, Chu K, Banks C, Greenslade J, Keijzers G, Thom O et al Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial. Ann Emerg Med. 2016;67(1):86\u201395.e2.","DOI":"10.1016\/j.annemergmed.2015.06.001"},{"issue":"3","key":"608_CR8","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00240-013-0551-1","volume":"41","author":"HA Aldaqadossi","year":"2013","unstructured":"Aldaqadossi HA. Stone expulsion rate of small distal ureteric calculi could be predicted with plasma C-reactive protein. Urolithiasis. 2013;41(3):235\u20139.","journal-title":"Urolithiasis"},{"issue":"5","key":"608_CR9","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3349\/ymj.2017.58.5.988","volume":"58","author":"KS Lee","year":"2017","unstructured":"Lee KS, Ha JS, Koo KC. Significance of neutrophil-to-lymphocyte ratio as a novel Indicator of spontaneous ureter stone passage. Yonsei Med J. 2017;58(5):988\u201393.","journal-title":"Yonsei Med J"},{"issue":"4","key":"608_CR10","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.juro.2015.04.104","volume":"194","author":"C \u00d6zcan","year":"2015","unstructured":"\u00d6zcan C, Aydo\u011fdu O, Senocak C, Damar E, Eraslan A, Oztuna D, et al. Predictive factors for spontaneous stone passage and the potential role of serum C-reactive protein in patients with 4 to 10 mm distal ureteral stones: a prospective clinical study. J Urol. 2015;194(4):1009\u201313.","journal-title":"J Urol"},{"issue":"8 Pt B","key":"608_CR11","doi-asserted-by":"publisher","first-page":"E339","DOI":"10.1111\/j.1464-410X.2012.11014.x","volume":"110","author":"S Sfoungaristos","year":"2012","unstructured":"Sfoungaristos S, Kavouras A, Katafigiotis I, Perimenis P. Role of white blood cell and neutrophil counts in predicting spontaneous stone passage in patients with renal colic. BJU Int. 2012;110(8 Pt B):E339\u201345.","journal-title":"BJU Int"},{"key":"608_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/bja\/83.4.602","volume":"83","author":"A Aouifi","year":"1999","unstructured":"Aouifi A, Piriou V, Blanc P, et al. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations. Br J Anaesth. 1999;83:602\u20137.","journal-title":"Br J Anaesth"},{"key":"608_CR13","unstructured":"Meisner M. Procalcitonin: a new innovative infection parameter. In: Meisner M, ed. Biochemistry. Stuttgart: Brahms Diagnostica; 2000: 15."},{"issue":"2","key":"608_CR14","first-page":"60","volume":"12","author":"B \u00c7ak\u0131ro\u011flu","year":"2016","unstructured":"\u00c7ak\u0131ro\u011flu B, Eyy\u00fcpo\u011flu E, Balc\u0131 MBC, Hazar A\u0130, Uyan\u0131k BS, Do\u011fan AN. The evaluation of the procalcitonin levels in chronic prostatitis patients. Nobel Med. 2016;12(2):60\u20135.","journal-title":"Nobel Med"},{"issue":"3","key":"608_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5152\/eurasianmedj.2016.0052","volume":"48","author":"Y Yuzbasioglu","year":"2016","unstructured":"Yuzbasioglu Y, Duymaz H, Tanrikulu CS, Halhalli HC, Koc MO, Tando\u011fan M, et al. Role of Procalcitonin in evaluation of the severity of acute Cholecystitis. Eurasian J Med. 2016;48(3):162\u20136.","journal-title":"Eurasian J Med"},{"issue":"3","key":"608_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.4103\/0974-7796.184877","volume":"8","author":"D Papagiannopoulos","year":"2016","unstructured":"Papagiannopoulos D, Whelan P, Ahmad W, Rybak J, Hota B, Deane L, et al. Procalcitonin is a strong predictor of urine culture results in patients with obstructing ureteral stones: a prospective, pilot study. Urol Ann. 2016;8(3):277\u201380.","journal-title":"Urol Ann"},{"issue":"5","key":"608_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.eururo.2006.01.045","volume":"50","author":"A Skolarikos","year":"2006","unstructured":"Skolarikos A, Alivizatos G, de la Rosette J. Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol. 2006;50(5):981\u201390 discussion 990.","journal-title":"Eur Urol"},{"issue":"1","key":"608_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.eururo.2014.01.011","volume":"66","author":"E Perez Castro","year":"2014","unstructured":"Perez Castro E, Osther PJ, Jinga V, Razvi H, Stravodimos KG, Parikh K, et al. CROES Ureteroscopy global study group. Differences in ureteroscopic stone treatment and outcomes for distal, mid-, proximal, or multiple ureteral locations: the clinical research Office of the Endourological Society ureteroscopy global study. Eur Urol. 2014;66(1):102\u20139.","journal-title":"Eur Urol"},{"issue":"6","key":"608_CR19","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1089\/end.2009.0670","volume":"24","author":"A Skolarikos","year":"2010","unstructured":"Skolarikos A, Laguna MP, Alivizatos G, Kural AR, de la Rosette JJ. The role for active monitoring in urinary stones: a systematic review. J Endourol. 2010;24(6):923\u201330.","journal-title":"J Endourol"},{"issue":"3","key":"608_CR20","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2214\/AJR.11.7276","volume":"198","author":"S Demehri","year":"2012","unstructured":"Demehri S, Steigner ML, Sodickson AD, Houseman EA, Rybicki FJ, Silverman SG. CT-based determination of maximum ureteral stone area: a predictor of spontaneous passage. AJR Am J Roentgenol. 2012;198(3):603\u20138.","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"608_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1442-2042.2011.02780.x","volume":"18","author":"LH Chau","year":"2011","unstructured":"Chau LH, Tai DC, Fung BT, Li JC, Fan CW, Li MK. Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial. Int J Urol. 2011;18(7):510\u20134.","journal-title":"Int J Urol"},{"key":"608_CR22","doi-asserted-by":"publisher","unstructured":"T\u00fcrk C, Knoll T, Seitz C, Skolarikos A, Chapple C, McClinton S;European Association of Urology. Medical expulsive therapy for Ureterolithiasis: the EAU recommendations in 2016. Eur Urol 2017;71(4):504\u2013507. doi:https:\/\/doi.org\/10.1016\/j.eururo.2016.07.024. Epub 2016 Aug 6. PubMed PMID: 27506951.","DOI":"10.1016\/j.eururo.2016.07.024"},{"issue":"2","key":"608_CR23","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1089\/end.2018.0614","volume":"33","author":"WD Brubaker","year":"2019","unstructured":"Brubaker WD, Dallas KB, Elliott CS, Pao AC, Chertow GM, Leppert JT, Conti SL. Payer type, race\/ethnicity, and the timing of surgical Management of Urinary Stone Disease. J Endourol. 2019;33(2):152\u20138.","journal-title":"J Endourol"},{"issue":"1","key":"608_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.juro.2012.02.2569","volume":"188","author":"BR Matlaga","year":"2012","unstructured":"Matlaga BR, Jansen JP, Meckley LM, Byrne TW, Lingeman JE. Treatment of ureteral and renal stones: a systematic review and meta-analysis of randomized, controlled trials. J Urol. 2012;188(1):130\u20137.","journal-title":"J Urol"},{"key":"608_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-2490-14-27","volume":"14","author":"A Fazlioglu","year":"2014","unstructured":"Fazlioglu A, Salman Y, Tandogdu Z, Kurtulus FO, Bas S, Cek M. The effect of smoking on spontaneous passage of distal ureteral stones. BMC Urol. 2014;14:27.","journal-title":"BMC Urol"},{"issue":"11","key":"608_CR26","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1007\/s11255-017-1677-9","volume":"49","author":"Z Bayraktar","year":"2017","unstructured":"Bayraktar Z, Albayrak S. Sexual intercourse as a new option in the medical expulsive therapy of distal ureteral stones in males: a prospective, randomized, controlled study. Int Urol Nephrol. 2017;49(11):1941\u20136.","journal-title":"Int Urol Nephrol"},{"key":"608_CR27","doi-asserted-by":"crossref","unstructured":"Ahmed AF, Gabr AH, Emara AA, Ali M, Abdel-Aziz AS, Alshahrani S. Factors predicting the spontaneous passage of a ureteric calculus of \u2a7d10 mm. Arab J Urol. 2015;13(2):84\u201390.","DOI":"10.1016\/j.aju.2014.11.004"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00608-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-020-00608-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-020-00608-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,18]],"date-time":"2021-04-18T23:15:10Z","timestamp":1618787710000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-020-00608-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1186\/s12894-020-00608-3","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,19]]},"assertion":[{"value":"4 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written ethics committee approval numbered 2016\u20135 was obtained from the ethics committee of GOP Taksim Education and Research Hospital for this study with a Helsinki declaration. Written informed consent for the current study was received from all patients and healthy volunteers.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declares that they have no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}